Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Vietnam Medi-Pharm Exp...Vietnam Medi-Pharm Expo
Not Confirmed
Not Confirmed
06-09 May, 2026
Bangladesh Pharma ExpoBangladesh Pharma Expo
Not Confirmed
Not Confirmed
07-09 May, 2026
Not Confirmed
Not Confirmed
10-14 May, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Vietnam Medi-Pharm Exp...Vietnam Medi-Pharm Expo
Industry Trade Show
Not Confirmed
06-09 May, 2026
Bangladesh Pharma ExpoBangladesh Pharma Expo
Industry Trade Show
Not Confirmed
07-09 May, 2026
Industry Trade Show
Not Confirmed
10-14 May, 2026
Digital content

29 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/29/3283559/31990/en/agios-reports-first-quarter-2026-financial-results-and-provides-business-update.html

06 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/06/3268336/31990/en/Agios-to-Host-First-Quarter-2026-Financial-Results-Conference-Call-and-Webcast-on-April-29-at-8-00-a-m-ET.html

31 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/31/3265325/31990/en/Agios-Advances-Mitapivat-Toward-Potential-U-S-Accelerated-Approval-in-Sickle-Cell-Disease-Following-Pre-sNDA-Meeting-with-FDA.html

12 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/12/3237003/31990/en/Agios-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

26 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/26/3225475/31990/en/Agios-to-Host-Fourth-Quarter-and-Full-Year-2025-Financial-Results-Conference-Call-and-Webcast-on-February-12-at-8-00-a-m-ET.html

12 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/12/3216709/31990/en/Agios-Outlines-2026-Strategic-Priorities-and-Key-Milestones-to-Accelerate-Rare-Disease-Portfolio-Growth.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE